Table 4.

Program outcome results

Outcome	Pre-implementation	Post-implementation	Difference or RoM (95% CI)	p-value
QoR-15: mean (SD)a
Day 1	106.13 (22.86)	103.83 (21.31)	Diff −3.96 (−9.41, 1.49)	0.154
Day 2	116.13 (21.73	115.04 (20.96)	Diff −1.94 (−7.25, 3.38)	0.476
Week 6 (primary outcome)	128.87 (17.10)	131.14 (13.50)	Diff 1.09 (−3.31, 5.49)	0.628
Worst NRS score: mean (SD)b
Day 1 (rest)	3.73 (2.92)	4.14 (3.14)	Diff 0.33 (−0.45, 1.11)	0.401
Day 1 (movement)	5.35 (2.60)	5.46 (2.81)	Diff 0.14 (−0.53, 0.81)	0.681
Day 2 (rest)	2.54 (2.27)	3.00 (2.67)	Diff 0.43 (−0.20, 1.07)	0.183
Day 2 (movement)	4.52 (2.61)	4.78 (2.58)	Diff 0.28 (−0.39, 0.96)	0.414
Week 6 (rest)	1.18 (1.88)	0.92 (1.38)	Diff −0.19 (− 0.66, 0.29)	0.444
Week 6 (movement)	1.76 (2.25)	1.89 (2.21)	Diff 0.19 (−0.46, 0.85)	0.562
OME consumption (mg/day): mean (SD)c
Day 1	75 (45, 120)	75 (46, 105)	Diff −5.0 (−20.21, 10.21)	0.518
Day 2	45 (30, 75)	50 (30, 75)	Diff 0 (−11.94, 11.94)	> 0.999
Week 6	0 (0, 15)	0 (0, 0)	Diff 0 (− 10.90, 10.90)	> 0.999
10MWT (minutes): median (Q1; Q3)
Day 3	0.40 (0.28; 0.71)	0.47 (0.26; 0.60)	Diff 0.04 (−0.06, 0.15)	0.440
Duration of hospital stay (days): mean (SD)
Entire group	5.94 (5.21)	5.02 (2.46)	RoM 0.89 (0.74, 1.07)	0.212
Unadjusted comparison			RoM 0.84 (0.70, 1.02)	0.072
Subgroup	5.91 (5.35)	4.89 (1.97)	RoM 0.86 (0.71, 1.04)	0.114
Unadjusted comparison			RoM 0.83 (0.68, 1.00)	0.051
WHODAS 2.0 score: mean (SD)
Week 6	18.17 (7.06)	17.97 (6.37)	Diff 0.40 (−1.42, 2.22)	0.663
Unplanned hospital readmission: n(%)	5 (4.35)	8 (6.96)

Abbreviations: NRS numeric rating scale, OME oral morphine equivalents, Q1 25th percentile, Q3 75th percentile, QoR-15 Quality of Recovery-15, RoM ratio of means

^aadjusted for pre-operative QoR-15, respiratory disease, preoperative anaemia and history of PONV.

^badjusted for pre-operative NRS score, respiratory disease, preoperative anaemia and history of PONV

^cadjusted for pre-operative OME, respiratory disease, preoperative anaemia and history of PONV